Press release
Crohn's Disease Market Report: Detailed Insights and Key Player Analysis-GlaxoSmithKline plc. F. Hoffmann-La Roche Ltd, Novartis AG.
The Crohn's Disease Market study by DataM Intelligence offer an in-depth analysis of the market, presenting insightful observations, statistics, historical data, and industry-validated market insights. The report delves into the competitive positioning of key companies, examining factors such as product offerings, pricing strategies, financial health, product portfolios, growth initiatives, and geographical reach.Download a Free sample PDF (Use Corporate email ID to Get Higher Priority) at: - https://datamintelligence.com/download-sample/crohns-disease-market
What is the projected growth rate (CAGR) of the Global Crohn's Disease market from 2024 to 2031?
Global Crohn's Disease market is estimated to grow at a CAGR Of 3.5% during the forecast period 2024-2031.
The Crohn's Disease market centers on treatments for Crohn's, a chronic inflammatory bowel disease affecting the digestive tract, leading to symptoms like abdominal pain, severe diarrhea, and malnutrition. This market includes pharmaceuticals such as anti-inflammatory drugs, immunosuppressants, biologics, and, increasingly, biosimilars. Market growth is driven by the rising incidence of Crohn's disease, advancements in biologic therapies, and increasing awareness of the disease. Additionally, ongoing research on more effective and personalized treatments, coupled with the demand for improved patient quality of life, further supports market expansion.
Key Developments:
In July 2017, Merck launched RENFLEXIS (infliximab-abda) in the U.S., a biosimilar to the biologic medicine Remicade (infliximab). RENFLEXIS is approved for reducing symptoms and achieving and maintaining clinical remission in adult patients with moderately to severely active Crohn's disease. This introduction provided a more affordable alternative for Crohn's disease patients, expanding access to a treatment with proven effectiveness in managing this chronic condition.
List of the Key Players in the Crohn's Disease Market:
GlaxoSmithKline plc. F. Hoffmann-La Roche Ltd, Novartis AG, Eli Lilly And Company., AstraZeneca, Pfizer Inc., Takeda Pharmaceutical Company Limited., Bristol-Myers Squibb Company, Shaanxi Yuantai Biological Technology Co., Ltd. HEFEI JOYE IMPORT & EXPORT CO., LTD. among others.
Research Process:
Both primary and secondary data sources have been used in the global Crohn's Disease Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Segment Covered in the Crohn's Disease Market:
By Drug Class: Anti-diarrheal, Anti-inflammatory drugs, Immunosuppressors, Antibiotics, Biologics, Pain relievers.
By Route of Administration: Injectable, Oral.
By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy.
Regional Breakout:
The global Crohn's Disease Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa.
Get Discounts on Premium Report:- https://www.datamintelligence.com/buy-now-page?report=crohns-disease-market
Regional Analysis:
The global Crohn's Disease Market report focuses on six major regions: North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Crohn's Disease Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.
**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**
Chapter Outline:
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: key insights, key emerging trends, etc.
Chapter 3: Manufacturers competitive analysis, detailed analysis of New Zealand Food Testing and Certification manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 5 & 6: Revenue of New Zealand Food Testing and Certification in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: The main points and conclusions of the report.
Get Customization in the report as per your requirements:- https://datamintelligence.com/customize/crohns-disease-market
Frequently Asked Questions
What is the expected growth rate of the global market for the forecast period?
What are the key driving factors that are responsible to shape the fate of the Crohn's Disease market during the forecast period?
What will be the overall size of the market during the analysis period?
What are the prominent market trends which influence the development of the Crohn's Disease market across various regions?
Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?
What are the challenges and threats that are likely to act as a barrier to the growth of the Crohn's Disease market?
What are the major opportunities that the companies can get to attain success in the world?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Crohn's Disease Market Report: Detailed Insights and Key Player Analysis-GlaxoSmithKline plc. F. Hoffmann-La Roche Ltd, Novartis AG. here
News-ID: 3720520 • Views: …
More Releases from DataM Intelligence 4Market Research

United States Peripheral Neuropathy Market Set for Transformative Growth with Ri …
Market Size and Growth:
The Peripheral Neuropathy Market size was valued US$ 1,539 million in 2021 and is estimated to reach US$ YY million by 2031, growing at a CAGR of 4.2% during the forecast period (2024-2031).
The Peripheral Neuropathy Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market participants…

United States Acute Coronary Syndrome Market Set for Robust Growth with Advancem …
Market Size and Growth:
The Global Acute Coronary Syndrome Market size reached US$ 9.94 billion in 2023 and is expected to reach US$ 14.70 billion by 2031, growing at a CAGR of 5.1% during the forecast period 2024-2031.
The Acute Coronary Syndrome Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for…

United States Atrial Fibrillation Market Surges with Breakthrough Therapies and …
Market Size and Growth:
The Global Atrial Fibrillation Market size reached US$ 26.75 billion in 2024 and is expected to reach US$ 63.79 billion by 2033, growing at a CAGR of 10.6 % during the forecast period 2025-2033.
The Atrial Fibrillation Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in the market and provides recommendations for market…

United States Personalized Cancer Vaccines Market Set for Breakthrough Growth wi …
Market Size and Growth:
The Global Personalized Cancer Vaccines Market size reached US$ 11.33 Billion in 2024 from US$ 10.21 Billion in 2023 and is expected to reach US$ 30.12 Billion by 2033, growing at a CAGR of 11.5% during the forecast period 2025-2033.
The Personalized Cancer Vaccines Market report by DataM Intelligence provides insights into the latest trends and developments in the market. This report identifies the key growth opportunities in…
More Releases for Crohn
Global IBD Ulcerative Colitis And Crohn S Disease Treatment Industry Poised for …
The IBD Ulcerative Colitis And Crohn S Disease Treatment Market research report offers crucial insights into how the industry is evolving, highlighting key drivers of growth and the main revenue streams expected between 2024 and 2032. Similar to a compass, it helps businesses navigate the market's complexities by showcasing both the present situation and the newest developments influencing its direction. For businesses, stakeholders, and industry participants, this report serves as…
Global Companion Animal Specialty Drugs and Crohn s Disease Drug (COVID-19 Imapa …
The Companion Animal Specialty Drugs Market ( https://bit.ly/31KDIZZ ) report is intended to function as a supportive means to assess the Companion Animal Specialty Drugs market along with the complete analysis and clear-cut statistics related to this market. In other words, the report would provide an up-to-date study of the market in terms of its latest trends, present scenario, and the overall market situation. Further, it will also help the…
Crohn’s Disease Drugs Market Research and Clinical Analysis 2020 - Bayer AG, Amg …
The Crohn's Disease Drugs Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Order a Copy of…
Crohn s Disease Drug Market to Witness Huge Growth by 2025 | AbbVie, Janssen Bio …
HTF MI recently introduced Global Crohn s Disease Drug Market study with in-depth overview, describing about the Product / Industry Scope and elaborates market outlook and status to 2023. The market Study is segmented by key regions which is accelerating the marketization. At present, the market is developing its presence and some of the key players from the complete study are AbbVie, Janssen Biotech, UCB, Amgen, Tillotts Pharma & Takeda…
Crohn Disease Market 2018 by its Scientific Reviews, Clinical Application and Ke …
Global Crohn Disease Market Professional Survey Report 2018 to 2025 presents an in-depth assessment of the Crohn Disease Market including enabling key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Crohn Disease Market investments from 2018 till 2025.
This study answers several questions for stakeholders, primarily which market segments…
Crohn Disease Market Set for Expansive Growth by 2022
This report studies the global Crohn Disease market, analyzes and researches the Crohn Disease development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Johnson & Johnson
Pfizer
Sanofi
Merck
GSK
AbbVie
Takeda
Ferring
UCB
Boehringer Ingelheim
Ask for sample copy @ http://www.researchtrades.com/request-sample/1117798
Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia
Market segment by Type, Crohn Disease can be split into
Small Intestine and Ileocephalitis
Colon Disease
Market segment…